| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 42 |
| 1 | METHOTREXATE SODIUM | 41 |
| 2 | PREDNISOLONE | 40 |
| 3 | PREDNISOLONE ORAL | 40 |
| 4 | PREDNISOLONE ORAL SOLUTION | 40 |
| 5 | METHOTREXATE | 39 |
| 6 | PREDNISONE | 34 |
| 7 | LAMIVUDINE | 20 |
| 8 | CYCLOPHOSPHAMIDE | 19 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 1 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 2 | AMIFOSTINE | 1 | 0.0012 |
| 3 | AMIKACIN SULFATE | 2 | 0.0011 |
| 4 | LOPINAVIR AND RITONAVIR | 15 | 0.0011 |
| 5 | ZIDOVUDINE | 9 | 0.0009 |
| 6 | EFAVIRENZ | 9 | 0.0008 |
| 7 | LAMIVUDINE | 20 | 0.0008 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 6 | 0.0008 |
| 9 | GEFITINIB | 7 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 26 | 0.0005 |
| 2 | Antimalarial [EPC] | 5 | 0.0005 |
| 3 | Antiprotozoal [EPC] | 5 | 0.0005 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0005 |
| 5 | Protease Inhibitor [EPC] | 20 | 0.0004 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 20 | 0.0003 |
| 7 | Calcitonin [EPC] | 1 | 0.0003 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 31 | 0.0003 |
| 9 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |